Why This Seattle Biotech Could be an M&A Target Post author:Sam Post published:January 18, 2018 Post category:BioPharma Immune Design is a clinical-stage immunotherapy company. Source: BioSpace You Might Also Like <b>GBSI</b> Biopolicy Summit 2017 Explores Newest Lab Automation, Digital Tools And Technologies Promising Improved Preclinical Research Reproducibility — October 16 In San Francisco September 6, 2017 Millendo Therapeutics Sweeps Up Phase II Asset With Acquisition of Small Biotech December 19, 2017 CRO Giant PAREXEL Explores $4 Billion Sale, Stock Jumps May 8, 2017
<b>GBSI</b> Biopolicy Summit 2017 Explores Newest Lab Automation, Digital Tools And Technologies Promising Improved Preclinical Research Reproducibility — October 16 In San Francisco September 6, 2017
